Neuropsychological Norms for Ethnically Diverse Florida Elders

Sponsor
University of South Florida (Other)
Overall Status
Unknown status
CT.gov ID
NCT03199378
Collaborator
Mayo Clinic (Other), Mt. Sinai Medical Center, Miami (Other), Florida Department of Health (Other)
350
3
14.9
116.7
7.8

Study Details

Study Description

Brief Summary

The goal of this proposal is to collect normative data from a sample of ethnically diverse Florida elders on a brief, standardized neuropsychological test battery . The norms collected in this multi-cultural dataset will provide appropriate corrections for demographic and sociocultural variables that contribute to performance variance on neuropsychological tests. By accounting for these variables, the normative corrections will improve specificity and eliminate disparities in diagnostic validity and clinical utility of neuropsychological tests when administered to Florida's ethnic minority elders.

Condition or Disease Intervention/Treatment Phase
  • Other: Neuropsychological Testing

Study Design

Study Type:
Observational
Anticipated Enrollment :
350 participants
Observational Model:
Ecologic or Community
Time Perspective:
Prospective
Official Title:
Neuropsychological Norms for Ethnically Diverse Florida Elders
Actual Study Start Date :
Jun 3, 2016
Anticipated Primary Completion Date :
Sep 1, 2017
Anticipated Study Completion Date :
Sep 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Caucasian

English speaking Caucasian individuals

Other: Neuropsychological Testing
Each group will be administered a battery of neuropsychological tests

African American

English speaking African American individuals

Other: Neuropsychological Testing
Each group will be administered a battery of neuropsychological tests

Hispanic

Spanish speaking Hispanic individuals

Other: Neuropsychological Testing
Each group will be administered a battery of neuropsychological tests

Outcome Measures

Primary Outcome Measures

  1. Neuropsychological norms [1 year]

    Norm referenced scores from the sample population

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years to 105 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Age 60 or above.

  • Any gender.

  • Primary language of English or Spanish.

  • Self-identifies as Hispanic, non-Hispanic Black/African American, or non-Hispanic Caucasian.

  • Global Clinical Dementia Rating (CDR) score = 0.

Exclusion Criteria:
  • Memory decline reported by participant, informant (if available), or study clinician.

  • Currently uncontrolled health condition that could affect cognition.

  • Abnormal findings on current neurologic examination.

  • History of chronic neurological diseases (stroke, active seizure disorder, parkisonism, TBI with subsequent cognitive change.

  • Current substance abuse or history of substance dependence.

  • History of chronic psychiatric disease (Bipolar disorder, schizophrenia).

  • Currently active mood disorder. History of depression or anxiety is acceptable if symptoms are controlled (Score <6 on the Geriatric Depression Scale). If taking psychoactive mood medication dosage must be stable for at least one month prior to testing.

  • Use of cognitive enhancing medications (i.e. cholinesterase inhibitors, memantine).

  • Need for assistance in activities of daily living due to cognitive reasons.

  • Sensorimotor deficits that would interfere with ability to perform neuropsychological tests.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mayo Clinic Florida Jacksonville Florida United States 32224
2 Mt. Sinai Medical Center Miami Florida United States 33136
3 University of South Florida Tampa Florida United States 33612

Sponsors and Collaborators

  • University of South Florida
  • Mayo Clinic
  • Mt. Sinai Medical Center, Miami
  • Florida Department of Health

Investigators

  • Principal Investigator: John Lucas, Ph.D, Mayo Clinic

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of South Florida
ClinicalTrials.gov Identifier:
NCT03199378
Other Study ID Numbers:
  • FloridaElderNorms
First Posted:
Jun 26, 2017
Last Update Posted:
Jun 26, 2017
Last Verified:
Jun 1, 2017
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jun 26, 2017